We work with the UK Government’s two major funding bodies, the Medical Research Council (MRC) and National Institute of Health Research (NIHR) to make type 1 diabetes research a priority.
We are a member of the Association of Medical Research Charities (AMRC), working to save and improve lives through research and innovation. This sees us support the AMRC’s Research at Risk campaign, which aims to address and mitigate the impact of the Covid-19 pandemic on research and development.
We also work with government departments, like the Department for Business, Energy, and Industrial Strategy, to help them understand the impact of type 1 diabetes on the UK, and the excellence in research that the UK can provide to the global mission to cure type 1.
We also work with researchers and other funders to create new opportunities for funding, and to understand and address some of the barriers that can slow down research progress in the UK.
Connect Immune Research
We are part of a coalition of charities, investigating how immune disorders are linked, called Connect Immune Research. We advocate for the development of a connected research community focused on autoimmune conditions across the UK to generate advances in knowledge and treatments for people living with autoimmune conditions, particularly type 1 diabetes.
Read our “Are You #AutoImmune Aware?” Report